Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
By Ludwig Burger FRANKFURT Zealand Pharma and partner Boehringer Ingelheim said their experimental obesity drug achieved up to
1970-01-01 08:00
How promising are new drugs to treat obesity and who should — and shouldn't — use them? Our medical analyst explains
How do the diabetes drugs semaglutide and tirzepatide work to reduce obesity? How promising are they to treat obesity? What are their side effects? Who is eligible to take them? CNN Medical Analyst Dr. Leana Wen answers these questions.
1970-01-01 08:00